Petrichor Healthcare Capital Management

Petrichor Healthcare Capital Management is a private equity firm specializing in healthcare investments, focusing on biopharmaceuticals, medical technology, and diagnostics. The firm partners with world-class healthcare managers and businesses to provide customized investment structures and support. Since its inception, Petrichor has completed over 80 investments representing more than $5 billion in invested capital and has held over 30 board seats across the industry. The team comprises professionals from highly-regarded financial institutions, including OrbiMed Advisors and Fortress Investment Group, bringing a deep in-house understanding of healthcare products and services, including scientific, technical, and commercial expertise. This expertise, combined with experience investing across sectors, geographies, and capital structures, provides a strong competitive advantage in building successful companies. Petrichor's portfolio includes notable partners such as ClearPoint Neuro, CorneaGen, Cryoport, LumiraDx, and Persivia. The firm's strategic approach spans company formation through late-stage and commercial growth opportunities, maintaining a long-term and strategic focus to drive scientific and medical innovation. Petrichor's deep industry expertise creates portfolio relationships beyond capital, helping private or public companies around the world achieve their growth potential.